Latest news
Arcutis President and CEO Todd Watanabe Sells 4,375 Shares for $114,275 as Q2 Results Demonstrate Profitability - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 12:50:01 GMTArcutis Biotherapeutics, Inc. Q2 2026 Earnings Call Summary - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 12:30:00 GMTArcutis Biotherapeutics Inc (ARQT) (Q2 2026) Earnings Call Highlights: Revenue Surges 59% and ... - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 05:08:00 GMTArcutis Biotherapeutics Q2 Earnings Call Highlights - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 22:03:50 GMTArcutis Biotherapeutics, Inc. (ARQT) Q2 Earnings and Revenues Surpass Estimates - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 21:10:02 GMTEarnings To Watch: Arcutis Biotherapeutics Inc (ARQT) Q2 2026 -- GF Value Sees 57% Upside - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 13:36:19 GMTArcutis Biotherapeutics (ARQT) Heads Into Earnings With Its ZORYVE Story Still Shaping Valuation - Yahoo FinanceYahoo Finance · Thu, 30 Jul 2026 07:00:00 GMTArcutis Biotherapeutics, Inc. (ARQT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo FinanceYahoo Finance · Wed, 29 Jul 2026 07:00:00 GMT